leukemia

3 Biotech Stocks With Major Catalysts Incoming
3 Biotech Stocks With Major Catalysts Incoming
Motley Fool
Incyte
TG Therapeutics
Cara Therapeutics
CR845
opioids
ublituximab
leukemia
olumiant
rheumatoid arthritis
Flag link:
New CAR-T drug for leukemia, while effective, is ‘going to cost a fortune’
New CAR-T drug for leukemia, while effective, is ‘going to cost a fortune’
Stat
CAR-T
Novartis
drug pricing
CTL019
leukemia
Flag link:
Two cancer drug prices have already been hiked by 8% this year
Two cancer drug prices have already been hiked by 8% this year
Marketwatch
drug pricing
cancer
Amgen
Blincyto
Teva Pharmaceutical
Treanda
lymphoma
leukemia
Flag link:
Novartis backs Gamida Cell’s $40M raise to fund a looming PhIII study, marketing and manufacturing prep
Novartis backs Gamida Cell’s $40M raise to fund a looming PhIII study, marketing and manufacturing prep
Endpoints
Novartis
Gamida Cell
clinical trials
cell grafts
bone marrow
leukemia
lymphoma
Flag link:
Pfizer's leukemia drug approved by UK cost watchdog after previous rejection
Pfizer's leukemia drug approved by UK cost watchdog after previous rejection
BioPharma Dive
Pfizer
UK
Bosulif
NHS
leukemia
Flag link:
Pfizer Drug Wins U.K. Support Following Overhaul of Cancer Fund
Pfizer Drug Wins U.K. Support Following Overhaul of Cancer Fund
Bloomberg
Pfizer
Bosulif
leukemia
Flag link:
Martin Shkreli's Arrest Halts Leukemia Drug Trial
Martin Shkreli's Arrest Halts Leukemia Drug Trial
Fortune
Martin Shkreli
clinical trials
KB003
KaloBios
leukemia
Flag link:
Agios Pharma Plunges 15% Despite Strong Data for Leukemia Drug
Agios Pharma Plunges 15% Despite Strong Data for Leukemia Drug
Barron's
Agios Pharmaceuticals
AG-221
leukemia
Flag link:
Using Re-Engineered Immune Cells to Kill Leukemia Induces Lasting Remissions
Using Re-Engineered Immune Cells to Kill Leukemia Induces Lasting Remissions
The Street
leukemia
Novartis
Kite Therapeutics
Celgene
Bluebird Bio
Flag link:
MorphoSys and Xencor Publish Final Results from Phase 1/2a Trial of MOR208 (XmAb5574) in CLL/SLL at ASH Annual Meeting
MorphoSys and Xencor Publish Final Results from Phase 1/2a Trial of MOR208 (XmAb5574) in CLL/SLL at ASH Annual Meeting
Yahoo/PR Newswire
MorphoSys
Xencor
MOR208
chronic lymphocytic leukemia
leukemia
Flag link:
Amgen Announces New Data From Phase 2 BLINCYTO™ (blinatumomab) Immunotherapy Study In Patients With Acute Lymphoblastic Leukemia And Minimal Residual Disease
Amgen Announces New Data From Phase 2 BLINCYTO™ (blinatumomab) Immunotherapy Study In Patients With Acute Lymphoblastic Leukemia And Minimal Residual Disease
Yahoo/PR Newswire
Amgen
Blincyto
acute lymphoblastic leukemia
leukemia
Flag link:
Seattle Genetics Presents Data from SGN-CD19A Antibody-Drug Conjugate at ASH Annual Meeting
Seattle Genetics Presents Data from SGN-CD19A Antibody-Drug Conjugate at ASH Annual Meeting
Yahoo/BusinessWire
Seattle Genetics
SGN-CD19A
acute lymphoblastic leukemia
leukemia
non-Hodgkin's lymphoma
diffuse large B-cell lymphoma
Flag link:
Agios Cancer 'Metabolism' Drug Clears Bone Marrow of Leukemic Cells
Agios Cancer 'Metabolism' Drug Clears Bone Marrow of Leukemic Cells
TheStreet.com
Agios Pharmaceuticals
leukemia
AG-120
AML
Flag link:
Geron Collaborates with J&J for Imetelstat
Geron Collaborates with J&J for Imetelstat
Yahoo/Zacks
Geron
JNJ
imetelstat
myelofibrosis
acute myelogenous leukemia
myelodysplastic syndrome
leukemia
Flag link:
The Best Blood Cancer Drug Launch Ever?
The Best Blood Cancer Drug Launch Ever?
Forbes
Pharmacyclics
Imbruvica
leukemia
Flag link:
Novartis apologizes for not disclosing side-effects of leukemia drugs sooner
Novartis apologizes for not disclosing side-effects of leukemia drugs sooner
Reuters
Novartis
side effects
Japan
leukemia
Flag link:
Agios Pharmaceuticals announces AG-221 orphan drug designation
Agios Pharmaceuticals announces AG-221 orphan drug designation
Yahoo/The Fly on the Wall
Agios Pharmaceuticals
AG-221
acute myelogenous leukemia
leukemia
Flag link:
Results from Phase III Study (AML-001) of VIDAZA® (Azacitidine for Injection) in Acute Myeloid Leukemia Presented at EHA
Results from Phase III Study (AML-001) of VIDAZA® (Azacitidine for Injection) in Acute Myeloid Leukemia Presented at EHA
Yahoo/BusinessWire
acute myeloid leukemia
leukemia
Vidaza
Celgene
Flag link:
AbbVie Presents New Results from Studies of Investigational Oncology Compound ABT-199/GDC-0199 at the 2014 American Society of Clinical Oncology Annual Meeting
AbbVie Presents New Results from Studies of Investigational Oncology Compound ABT-199/GDC-0199 at the 2014 American Society of Clinical Oncology Annual Meeting
Yahoo/PR NewsWire
AbbVie
ABT-199
chronic lymphocytic leukemia
leukemia
non-Hodgkin's lymphoma
Flag link:
Pharmacyclics' Imbruvica Extends Survival in Elderly Leukemia Patients
Pharmacyclics' Imbruvica Extends Survival in Elderly Leukemia Patients
The Street
Pharmacyclics
Imbruvica
leukemia
Flag link:

Pages